You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Article metrics

Article menu

Download PDFPDF

Infections
Original research
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

 

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

AbstractFullPdf
Apr 202217881797125
May 202227828661
Jun 2022979429
Jul 2022838125
Aug 2022817724
Sep 2022918349
Oct 2022706718
Nov 2022737131
Dec 2022666016
Jan 202311410917
Feb 2023625824
Mar 2023484218
Apr 2023302513
May 2023302719
Jun 202342378
Jul 2023282219
Aug 202329249
Sep 202326279
Oct 202319157
Nov 2023352611
Dec 202335226
Jan 2024313128
Feb 2024302126
Mar 2024333060
Total32193132652